Diadema Partners »

4d Molecular Therapeutics In shares owned by Diadema Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.6M 571k 13.30

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding 4d Molecular Therapeutics In

Jupiter Topco
Henderson Group
RA Capital Management
BlackRock
Goldman Sachs Group
Novo A/S
BVF
State Street Corporation
Adage Capital Partners GP
Trails Edge Capital Partners
Vanguard Capital Management
Armistice Capital
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In